Major Study Links Common Dementia Drug to Stroke Risk in All Patient Groups
UK study of 165,000 dementia patients finds risperidone increases stroke risk across all groups, challenging safety assumptions.
Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
177 articles
UK study of 165,000 dementia patients finds risperidone increases stroke risk across all groups, challenging safety assumptions.
Researchers turned ordinary brain cells into plaque-clearing machines, reducing Alzheimer's amyloid by half in mice with one treatment.
Scientists discover that subtle changes in blood protein structure can identify Alzheimer's earlier than current tests.
New research reveals how tiny plastic particles we consume daily could damage brain cells through five key biological pathways.
Scientists find that TDP43 protein regulates DNA repair systems, linking neurodegeneration to cancer when repair goes wrong.
UCLA research links chlorpyrifos pesticide exposure to 2.5x higher Parkinson's risk by damaging brain's protein cleanup system.
Seven-year study reveals hearing aids protect against dementia even when cognitive tests show no improvement.
New research reveals depression often appears years before Parkinson's or dementia diagnosis, suggesting it reflects early brain changes.
Speed-of-processing training in adults 65+ showed lasting protection against dementia in groundbreaking 20-year study.
New AI system reveals how genes control each other in Alzheimer's brains, uncovering potential treatment targets.
Major study identifies three existing drugs that could be repurposed to fight Alzheimer's disease, offering faster path to treatment.
Common respiratory bacterium persists in retinas and brains, triggering inflammation and amyloid buildup linked to cognitive decline.